Bio Rad Laboratories, Inc. financial data

Symbol
BIO, BIO-B on NYSE
Industry
Laboratory Analytical Instruments
Location
1000 Alfred Nobel Drive, Hercules, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 636 % +13.6%
Quick Ratio 164 % +19.9%
Debt-to-equity 41.4 % +1.22%
Return On Assets -17.5 % -241%
Operating Margin 10.5 % -17.1%

Shares

Label TTM Value / Value Unit Change %
Weighted Average Number of Shares Outstanding, Basic 28.2M shares -3.41%
Weighted Average Number of Shares Outstanding, Diluted 28.2M shares -3.41%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.57B USD -3.92%
Research and Development Expense 296M USD +19.6%
Operating Income (Loss) 269M USD -20.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.34B USD -176%
Income Tax Expense (Benefit) -498M USD -134%
Net Income (Loss) Attributable to Parent -1.84B USD -189%
Earnings Per Share, Basic -65 USD/shares -203%
Earnings Per Share, Diluted -65 USD/shares -203%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 488M USD +20.9%
Accounts Receivable, after Allowance for Credit Loss, Current 453M USD -7.46%
Inventory, Net 760M USD -2.63%
Other Assets, Current 30.7M USD +17.6%
Assets, Current 3.03B USD -0.59%
Property, Plant and Equipment, Net 528M USD -0.17%
Operating Lease, Right-of-Use Asset 161M USD -17.6%
Intangible Assets, Net (Excluding Goodwill) 294M USD -8.39%
Goodwill 411M USD -0.75%
Other Assets, Noncurrent 102M USD +7.38%
Assets 9.36B USD -23.9%
Accounts Payable, Current 122M USD -15.4%
Employee-related Liabilities, Current 124M USD -11.2%
Liabilities, Current 468M USD -10.5%
Long-term Debt and Lease Obligation 1.2B USD +0.11%
Deferred Income Tax Liabilities, Net 818M USD -44.6%
Operating Lease, Liability, Noncurrent 131M USD -20.6%
Other Liabilities, Noncurrent 177M USD -9.13%
Liabilities 2.79B USD -21.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -538M USD -60.2%
Retained Earnings (Accumulated Deficit) 7.42B USD -19.9%
Stockholders' Equity Attributable to Parent 6.57B USD -24.8%
Liabilities and Equity 9.36B USD -23.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 69.8M USD -28.9%
Net Cash Provided by (Used in) Financing Activities 4.31M USD -99.6%
Net Cash Provided by (Used in) Investing Activities -43.1M USD +38.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 29.4M USD -1.92%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 490M USD +21.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 22.4M USD -0.25%
Deferred Tax Assets, Valuation Allowance 95.2M USD +78.9%
Deferred Tax Assets, Gross 251M USD -4.92%
Operating Lease, Liability 173M USD -15.9%
Payments to Acquire Property, Plant, and Equipment 40.2M USD +12.5%
Lessee, Operating Lease, Liability, to be Paid 196M USD -17.3%
Property, Plant and Equipment, Gross 1.64B USD +2.61%
Operating Lease, Liability, Current 41.7M USD +3.22%
Lessee, Operating Lease, Liability, to be Paid, Year Two 37.3M USD -17.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 46.8M USD +0.43%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 22.4M USD -26.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 28.7M USD -13.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 7.5M shares 0%
Unrecognized Tax Benefits 86.7M USD +2.36%
Lessee, Operating Lease, Liability, to be Paid, Year Four 21.6M USD -15.6%
Operating Lease, Payments 42.8M USD +4.39%
Additional Paid in Capital 463M USD +3.14%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 21.2M USD -10.9%
Deferred Tax Assets, Net of Valuation Allowance 156M USD -26.1%
Interest Expense 48.9M USD -1.01%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%